Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > News > MIV Therapeutics Drug-Eluting Stent Coating

September 24th, 2003

MIV Therapeutics Drug-Eluting Stent Coating

MIV Therapeutics Inc. has received a mid-point milestone interim progress report from the University of British Columbia (UBC) on the development of its proprietary HAp (hydroxyapatite) multi-layer coating with drug-eluting capabilities. "The research work on multi-layer coating applications is progressing on schedule. Our deposition methods have shown promising results with respect to nano-porosity and drug encapsulation for drug-eluting stents."

MIV Therapeutics

Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press


Extracellular vesicles could be personalized drug delivery vehicles March 15th, 2018

Department of Materials Test Engineering (WPT) at TU Dortmund University uses Deben CT5000TEC stage to perform X-ray micro-tomography experiments for better understanding of damage progression in composite materials March 13th, 2018

Scientists Use Nanotechnology to Detect Molecular Biomarker for Osteoarthritis March 13th, 2018

Polymer nanoparticle shows ability to locate and treat breast tumors March 13th, 2018

The latest news from around the world, FREE

  Premium Products
Only the news you want to read!
 Learn More
Full-service, expert consulting
 Learn More

Nanotechnology Now Featured Books


The Hunger Project